CRMD

CorMedix Inc.

7.63

USD

CRMD Earnings Reports

Positive Surprise Ratio

CRMD beat 25 of 40 last estimates.

63%

Next Report

Date of Next Report

Mar 23, 2026

Estimate for Q4 25 (Revenue/ EPS)

$130.07M

$0.85

Implied change from Q3 25 (Revenue/ EPS)

+24.74%

-32.54%

Implied change from Q4 24 (Revenue/ EPS)

+316.78%

+286.36%

CorMedix Inc. earnings per share and revenue

On Nov 12, 2025, CRMD reported earnings of 1.26 USD per share (EPS) for Q3 25, beating the estimate of 0.65 USD, resulting in a 91.46% surprise. Revenue reached 104.28 million, compared to an expected 87.74 million, with a 18.84% difference. The market reacted with a +2.06% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 9 analysts forecast an EPS of 0.85 USD, with revenue projected to reach 130.07 million USD, implying an decrease of -32.54% EPS, and increase of 24.74% in Revenue from the last quarter.

FAQ

What were CorMedix Inc.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, CorMedix Inc. reported EPS of $1.26, beating estimates by 91.46%, and revenue of $104.28M, 18.84% above expectations.

How did the market react to CorMedix Inc.'s Q3 2025 earnings?

The stock price moved up 2.06%, changed from $11.19 before the earnings release to $11.42 the day after.

When is CorMedix Inc. expected to report next?

The next earning report is scheduled for Mar 23, 2026.

What are the forecasts for CorMedix Inc.'s next earnings report?

Based on 9 analysts, CorMedix Inc. is expected to report EPS of $0.85 and revenue of $130.07M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.